Antibody Diagnostics

ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.

Antibody Therapeutics

ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.

About ModiQuest

Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.

Latest News

• ModiQuest to Offer Ligand’s OmniAb Service in Europe
• ImmunoPrecise Signs Large Pharma Antibody Development Agreement
• ImmunoPrecise Announces Phage Display-Based Antibody Discovery Platforms
• IMMUNOPRECISE ANTIBODIES’ Q1 REVENUES INCREASE 386% OVER Q1 2017